These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 476268)

  • 1. Immuno-heterogeneity of the calcitonins of hypercalcemia, breast and lung cancers and medullary carcinoma of thyroid.
    Roof BS; Weinstein R; Vujic I; Burdash NM
    Biomedicine; 1979 Jun; 30(2):82-90. PubMed ID: 476268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunochemical heterogeneity of calcitonin in plasma of patients with medullary thryoid carcinoma.
    Sizemore GW; Hpeath H; Larson JM
    J Clin Invest; 1975 May; 55(5):1111-8. PubMed ID: 47335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity of immunoreactive calcitonin in extracts of normal human thyroid.
    Woloszczuk W; Kovarik J
    Horm Metab Res; 1981 Aug; 13(8):460-3. PubMed ID: 6173296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated CEA in breast cancer patients with overlooked medullary thyroid carcinoma.
    Andry G; Wildschutz T; Chantrain G; Bonnyns M; Dor P
    Eur J Surg Oncol; 1993 Jun; 19(3):305-8. PubMed ID: 8100201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of region specific radioimmunoassays for characterization of circulating calcitonin in patients with medullary carcinoma of the thyroid gland.
    Myhre L; Gautvik KM
    Acta Endocrinol (Copenh); 1979 Jul; 91(3):449-61. PubMed ID: 474037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioimmunoassay of human calcitonin in serum and tissue from healthy individuals and patients with medullary carcinoma of the thyroid gland.
    Gautvik KM; Normann T; Teig V; Wille SO; Brennhovd IO; Christensen I
    Scand J Clin Lab Invest; 1976 Jul; 36(4):323-9. PubMed ID: 959750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occurrence of calcitonin, somatostatin-like immunoreactivity, and carcinoembryonic antigen in two sisters suffering from familial thyroid medullary carcinoma.
    Bethge N; Ahuja S; Diel F
    Exp Clin Endocrinol; 1986 Dec; 88(3):365-72. PubMed ID: 2881797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A preliminary evaluation of calcitonin and PDN-21 as tumor markers for lung cancer. EORTC Lung Cancer Working Party.
    Body JJ; Dumon JC; Sculier JP; Dabouis G; Lacroix H; Libert P; Richez M; Bureau G; Mommen P; Raymakers N
    Henry Ford Hosp Med J; 1989; 37(3-4):190-3. PubMed ID: 2639133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcitonin in breast and lung cancer.
    Hillyard CJ; Coombes RC; Greenberg PB; Galante LS; MacIntyre I
    Clin Endocrinol (Oxf); 1976 Jan; 5(1):1-8. PubMed ID: 942890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum calcitonin-lowering effect of magnesium in patients with medullary carcinoma of the thyroid.
    Anast C; David L; Winnacker J; Glass R; Baskin W; Brubaker L; Burns T
    J Clin Invest; 1975 Dec; 56(6):1615-21. PubMed ID: 1202087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of immunoreactive calcitonin in extracts of medullary thyroid carcinoma.
    Rude RK; Matsumoto S; Singer FR
    Miner Electrolyte Metab; 1982 Jun; 7(6):292-7. PubMed ID: 6302462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypercalcitoninaemia in medullary carcinoma of the thyroid and other malignancies: value of calcitonin as tumour marker.
    Marrinan M; Skrabanek P; Moriarty M; McPartlin J; Powell D
    Horm Metab Res; 1982 Apr; 14(4):213-5. PubMed ID: 6282727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medullary thyroid carcinoma and calcitonin.
    Emmertsen K
    Dan Med Bull; 1985 Mar; 32(1):1-28. PubMed ID: 2859145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Plasma tumor markers (calcitonin and carcinoembryonic antigen) in medullary thyroid cancers].
    Argémi B; Vagneur JP; Conforto C; Even F; Rollat MC; Simonin R
    Bull Cancer; 1984; 71(2):133-9. PubMed ID: 6733293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medullary thyroid carcinoma: prognosis of familial versus nonfamilial disease and the role of radiotherapy.
    Samaan NA; Schultz PN; Hickey RC
    Horm Metab Res Suppl; 1989; 21():21-5. PubMed ID: 2807151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tumours markers. Calcitonin and carcinoembryonic antigen in medullary carcinoma of the thyroid (author's transl)].
    Calmettes C; Moukhtar MS; Milhaud G
    Presse Med (1893); 1979 Dec; 8(48):3947-50. PubMed ID: 530945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the presence of autoantibodies in the plasma of patients suffering from medullary carcinoma of the thyroid.
    Calmettes C
    Biomed Pharmacother; 1985; 39(4):195-8. PubMed ID: 3904856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between calcitonin and carcinoembryonic antigen levels in medullary carcinoma of the thyroid.
    Calmettes C; Moudktar MS; Milhaud G
    Biomedicine; 1977 Mar; 27(2):52-4. PubMed ID: 861349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medullary carcinoma of the thyroid gland in Norway. Serum calcitonin in 300 relatives of 43 patients.
    Normann T; Gautvik KM
    Ann Chir Gynaecol; 1977; 66(4):187-94. PubMed ID: 907311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carcinoembryonic antigen and calcitonin as markers of malignancy in medullary thyroid carcinoma.
    Cox CE; VanVickle J; Froome LC; Mendelsohn G; Baylin SB; Wells SA
    Surg Forum; 1979; 30():120-1. PubMed ID: 395674
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.